Introduction
Nucleophosmin (NPM) is a multifunctional protein initially characterized as a nucleolar protein functioning in the processing and transport of ribosomal RNA (1) . Evidence has established a positive relationship between the expression level of NPM and the proliferative state of the cell. Indeed, NPM is found to be more abundant in proliferative and cancer cells than in normal resting cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The synthesis of NPM is rapidly increased at early G 1 phase and closely correlated with proliferative induction by various mitogens (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Conversely, NPM expression is downregulated in cells undergoing differentiation or apoptosis (15,16). More recently, two murine Npm-knockout models demonstrate that Npm null mice die in utero with anemia and that Npmþ/À mice develop a myelodysplastic syndrome (17) (18) (19) . Additionally, in vitro studies show that NPM knockdown increased apoptosis in unstressed human hematopoietic cells (20, 21) .
One major function of NPM implicated in promoting cell proliferation is linked to its positive role in cell cycle regulation. One mechanism by which NPM promotes cell cycle progression is its influence on two important negative cell cycle regulators. Recently, it has been reported that NPM inhibited p53 in cells exposed to ultraviolet radiation and hypoxia (22, 23) . NPM also interacts with the alternate-reading-frame protein (ARF) tumor suppressor that activates p53-dependent cell cycle checkpoints by binding the ubiquitin ligase HDM2, which promotes p53 degradation (24, 25) . It has been shown that NPM stabilized p53 through direct interaction with HDM2 (26) .
Another role of NPM in promoting cell cycle progression is its function as an effector for several positive cell cycle regulators. For example, NPM is phosphorylated at Thr-199 by cyclin-dependent kinase Cdk2 in late G 1 phase to regulate centrosome duplication in dividing cells (27, 28) . NPM phosphorylation at Ser-125 by another cell cycle-related Ser/Thr protein kinase, casein kinase 2, serves to not only regulate NPM function during ribosome biosynthesis (29) but also enable NPM to perform its function as a molecular chaperone (30) . Phosphorylation of Ser-4 residue on NPM by the polo-like kinase 1 was reported to play a role in mitotic regulation (31) . It has also been shown that phosphorylation at Thr95 in the Nuclear export signal (NES) motif of NPM may regulate NPM's association with the centrosome (27) . In addition, NPM is phosphorylated on Thr234 and Thr237 by cyclin-dependent kinase (CDK) 1/cyclinB. This may correlate with NPM reassociation with the centrosome during mitosis (1, 32) . Recent studies suggest that the NPM phosphorylation and dephosphorylation cycle during mitosis depends upon the balance between the Cdk1 and the Protein phosphatase 1 (PP1) activity (33) . However, how NPM phosphorylation during mitosis functions to regulate cell cycle progression remains to be elucidated.
Fanconi anemia (FA) is a genetic disorder associated with bone marrow failure and cancers particularly leukemia and has been proposed as a genetic model system for studying these hematological malignancies. We recently demonstrated that overexpression of NPM suppresses oncogene-induced senescence and apoptosis and accelerates oncogenic transformation in cells deficient for the Fancc gene and the ataxia telangiectasia mutated (Atm) gene (34) . However, it is not clear whether these elevations of NPM expression represent a cause of transformation or an effect of other molecular events, in which FA progresses to malignancies.
In this study, we created a series of mutants targeting the consensus CDK phosphorylation sites to investigate the regulatory role for NPM phosphorylation in proliferation and cell cycle control. We found that phosphorylation of NPM at both Ser10 and Ser70 sites positively regulated Cdk1 activity, overrided stress-induced G 2 /M arrest, and increased blast engraftment in immunodeficient recipient mice.
(BD Biosciences, San Jose, CA). WinList (Verity, Topsham, ME) and FACSDiva (BD Biosciences, Franklin Lakes, NJ) software were used for cell cycle analysis.
Cell proliferation and mitotic index determination Cell proliferation was measured by 5#-bromo-2#-deoxyuridine incorporation. In brief, cells were cultured for 24 h with 10 lM 5#-bromo-2#-deoxyuridine (Sigma-Aldrich), harvested, fixed in 70% ethanol and then treated with 2 N HCl for 20 min at room temperature followed by addition of 0.1 M sodium borate. The cells were incubated with an anti-5#-bromo-2#-deoxyuridine mouse monoclonal antibody, washed and incubated with fluorescein isothiocyanate-conjugated anti-mouse antibody. Cells were counterstained overnight with 5 lg of propidium iodide per ml containing 40 lg of ribonuclease per microliter. The stained cells were analyzed by flow cytometry. Mitotic index analysis was performed by staining the harvested cells with aceto-orcein (Merck & Co., Whitehouse Station, NJ) in 60% acetic acid, with which condensed chromatin can easily be identified. Mitotic index was determined by counting the percentage of cells with condensed chromatin.
Preparation of cell extracts, immunoblotting and immunoprecipitation
Nuclear and cytosolic fractions of the cell extracts were prepared using a Nuclear extraction kit (BD Biosciences) in accordance to manufacturer's instruction. Approximately 100 lg of cell extracts were resolved on (10%) sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. Immunoblots were probed with antibodies for Flag (M2; Sigma-Aldrich), Cdk1, cyclin B1, Cdk1 In vitro kinase assay Cdk1 immunoprecipitates were resuspended in kinase buffer containing 20 mM 4-morpholinepropanesulfonicacid (pH 7.5), 25 mM b-glycerol phosphate, 5 mM ethyleneglycol-bis(aminoethylether)-tetraacetic acid, 1 mM dithiothreitol, 7.5 mM MgCl 2 , 1 mM sodium orthovanadate, 10 lg of histone H1 (Upstate Chemicon, Temecula, CA) and 50 mM adenosine triphosphate at 30°C for 30 min. Reactions were stopped by the addition of SDS sample buffer and heating at 95°C for 5 min. Reaction products were separated by SDS-polyacrylamide gel electrophoresis, and level of histone H1 phosphorylation were determined by western blot using the antibody specific for phospho-histone H1 (Upstate).
BM transplantation and establishment of NOD/SCID xenografts NOD/SCID mice (Jackson Laboratories) were irradiated in a single fraction of 275 cGy using a 135 Cs c irradiator. After irradiation, mice were injected with 1 Â 10 7 to 3 Â 10 7 lymphoblasts. Mice were screened for engraftment starting at 4 weeks after transplantation. Engraftment was detected by FACS analysis using antibodies recognizing human phycoerythrin-conjugated CD45 and fluorescein isothiocyanate-conjugated CD19 (BD Pharmingen, San Diego, CA). Twelve weeks after transplantation, animals were humanely killed, and bone marrow (BM) and peripheral blood were harvested for flow cytometry and Wright-Giemsa stain.
Construction of retroviral expression vectors and mutagenesis, retroviral mediated gene transfer and immunocytochemistry (see Supplementary Methods, available at Carcinogenesis Online).
Results
Opposite effects of phosphomimetic and non-phosphorylatable NPM mutants on G 2 /M cell cycle transition To study the regulatory role for NPM phosphorylation in proliferation and cell cycle control, we analyzed potential phosphorylation sites in human NPM sequence. We identified Ser10 (DMDMSPLRP), Ser70 (NYEGSPIKV) and Thr199 (SIRDTPAKN) as CDK phosphorylation sites (bold alphabets) (consensus S/TPX K/R; Figure 1A ) (35, 36) . Among them, Ser10 and Ser70 are previously unidentified phosphorylation sites. A series of mutants was created to mimic or abrogate phosphorylation at these sites. We expressed the NPM mutants in HSC536 lymphoblast cell, which is a lymphoblast cell line derived from a FA patient with BM failure and expresses negligible levels of endogenous NPM (37) , by retroviral gene transfer and verified their expression by western blot analysis (Supplementary Figure S1 is available at Carcinogenesis Online). We then tested the effect of NPM phosphorylation on cell proliferation. Cells expressing the phosphomimetic (E-substituted) NPM mutants showed enhanced proliferation ( Figure 1B ). The double phosphomimetic (S10E/S70E, NPM-EE) NPM mutants showed significantly more potent than the single Esubstituted mutants and additional phosphorylation at T199 (S10E/ S70E/T199E, NPM-EEE) did not enhance proliferation further. In contrast, the non-phosphorylatable A-substituted NPM mutants had reduced proliferative rate when compared with the E-substituted mutants ( Figure  1B ). Analysis of cell cycle profile of the mutant-expressing cells after release from DTB synchronization showed that NPM-EE promoted G 2 /M transition compared with wild-type (WT) NPM, as reflected by an early accumulation of G 2 /M cell population at 6 h after release and a progressive decrease of cells in G 2 /M phases during the period of 10-14 h post-release ( Figure 1C ). In contrast, NPM-AA induced a delay of cell cycle progression, showing that G 2 /M population remained high until 14 h. Consistent with this, phosphorylation at the S10 and S70 sites promoted mitotic entry, with .40% of the cells expressing NPM-EE in mitosis at 10 h after release ( Figure 1D ).
The S10 and S70 CDK phosphorylation sites contribute to the regulation of Cdk1 activity during G 2 /M transition It is well established that the G 2 /M checkpoint is controlled by the Cdk1 kinase (38) . Since NPM-EE promoted G 2 /M transition, we tested whether NPM phosphorylation at S10/S70 had a role in the regulation of Cdk1 kinase activity. We first immunoprecipitated Cdk1 protein from cells synchronized with DTB and then examined the effect of NPM phosphorylation on Cdk1 activity in an in vitro kinase assay. Although Flag-tagged NPM-AA and NPM-EE expression levels showed no change at each time points (Figure 2A ), expression of NPM-EE resulted in a strong increase in histone H1-associated Cdk1 activity during 8-10 h after release from the DTB compared with WT-NPM and vector controls ( Figure 2B ). In contrast, NPM-AA inhibited Cdk1 activity. These data demonstrate that phosphorylation at S10 and S70 plays a role in regulation of Cdk1 kinase activity during G 2 /M transition.
Simultaneous inactivation of S10 and S70 increases accumulation of inhibitory Cdk1 Tyr15 and cytoplasmic Cdc25C
We then investigated how S10/S70 dephosphorylation inhibited Cdk1 activity and whether reduced kinase activity was responsible for the G 2 /M cell cycle arrest. Since one critical biochemical event during G 2 /M arrest is inhibitory phosphorylation of Cdk1 at Tyr15 [Cdk1 Tyr15 ; (39)], we examined the effect of S10/S70 phosphorylation status on Cdk1 Tyr15 phosphorylation using an antibody specific for Cdk1 Tyr15 . Kinetic analysis showed that treatment of the vectortransduced cells with genotoxic agent etoposide induced optimal Cdk1 Tyr15 phosphorylation at 2 h after addition of the drug ( Figure  3A) . There was at least 2-fold increase in Cdk1 Tyr15 in cells expressing NPM-AA compared with NPM-EE-transduced cells ( Figure 3A) .
In mammalian cells, the inhibitory Cdk1 Tyr15 is dephosphorylated by the dual Cdc25A/Cdc25C phosphatases (38) . The kinase-inactive form of Cdk1 Tyr15 can be maintained by functional suppression of the phosphatases through proteasomal degradation of Cdc25A and phosphorylation-mediated sequestration of Cdc25C to the cytoplasm (38, 40) . We thus examined the effect of NPM-phosphorylated status on Cdc25A stability and Cdc25C sequestration. Immunoblot analysis of the whole cell extracts revealed no significant alterations in the levels of either Cdc25A or Cdc25C in etoposide-treated cells expressing the WT NPM, NPM-AA or NPM-EE proteins ( Figure 3B ). However, there was a strong increase of Cdc25C in the cytoplasmic extracts of NPM-AA-expressing cells compared with those transduced with the empty vector or WT NPM ( Figure 3C) . Thus, the dephosphorylation of S10 and S70 correlates with cytoplasmic sequestration of Cdc25C leading to inactivation of Cdk1.
Phosphorylation of NPM at both S10 and S70 sites is required for proper interaction between Cdk1 and Cdc25C Recently, it has been reported that a proper interaction between Cdk1 and Cdc25C is essential for successful mitosis (38, 40) . To further investigate the effect of S10/S70 phosphorylation on Cdc25C function, we compared the ability of Cdc25C to interact with the Cdk1 kinase in cells expressing the WT, S10A, S70A, NPM-AA, as well as S10E, S70E and NPM-EE proteins during mitosis. To this end, we utilized DTB combined with nocodazole to synchronize cells in the M phase. Neither Cdc25C nor Cdk1 levels were significantly different in these cell lines ( Figure 4A ). However, a higher Cdk1 Tyr15 :Cdk1 ratio was observed in NPM-AA-expressing cells than in those transduced with the vector control, WT NPM or NPM-EE ( Figure 4A) . Interestingly, NPM-AA expression reduced the association of Cdc25C with Cdk1, as compared with the single non-phosphorylatable mutants as well as the vector control ( Figure 4B ). In contrast, there was a strong increase in Cdc25C-Cdk1 interaction ( Figure 4B ) in NPM-EE cells. Therefore, the interaction between Cdc25C and Cdk1 appears to require phosphorylation at both S10 and S70 sites.
A functional link between S10/S70 phosphorylation and Cdc25C-Cdk1 interaction was further investigated by transfecting HEK293 cells with increasing amounts of Flag-tagged NPM double mutants as well as the corresponding single mutants. Cells were then synchronized in M phase. Increased expression of NPM-EE resulted in strong interaction between endogenous Cdc25C and Cdk1 compared with WT NPM control ( Figure 4C ). Conversely, high expression of the non-phosphorylatable double mutant NPM-AA almost completely abolished Cdc25C-Cdk1 association ( Figure 4D ). These results further support the notion that phosphorylation of both the S10 and S70 sites regulates the interaction between Cdc25C and Cdk1.
NPM-EE directly binds to Cdc25C and prevents phosphorylation of Cdc25C at Ser216
As phosphorylation of Cdc25C at Ser216 has been shown to induce cytoplasmic localization of the phosphatase (38,40), we next examined the effect of S10/S70 phosphorylation on Cdc25C-S216 phosphorylation and cytoplasmic sequestration of Cdc25C. Using whole cell extracts, we found that there was a very strong increase in phosphorylation of the Cdc25C protein at Ser216 in the NPM-AAexpressing cells compared with cells expressing the WT NPM protein ( Figure 5A, left panel) . This was confirmed by western analysis of cytoplasmic protein extracts from NPM-EE and NPM-AA expressing cells, which shows that there was an increased phosphorylated Cdc25C and total Cdc25C in the cytoplasm of NPM-AA expressing cells ( Figure 5A, right panel) . In addition, immunofluorescent staining demonstrated increased cytoplasmic localization of the phosphatase in NPM-AA cells ( Figure 5B ). In contrast, expression of NPM-EE inhibited both Ser216 phosphorylation and cytoplasmic accumulation of Cdc25C ( Figure 5A and B) . Interestingly, NPM-AA was localized in the nucleolus, whereas NPM-EE was dislocalized to the nucleoplasm (Supplementary Figure S2 is available at Carcinogenesis Online).
To study how NPM-EE prevents Cdc25C Ser216 phosphorylation and cytoplasmic accumulation, we asked whether NPM-EE associated with Cdc25C. We precipitated WT NPM, S10E, S70E and NPM-EE proteins from mitotic cells. Interestingly, the endogenous Cdc25C was present in the immunoprecipitates of NPM-EE but was undetectable in those of S10E or S70E mutant ( Figure 5C ), indicating that phosphorylation of both S10 and S70 sites mediates the binding of NPM to Cdc25C. Consistent with this, analysis of mitotic cytoplasmic fractions showed significantly reduced levels of Cdc25C in NPM-EE cells compared with those expressing the single mutant S10E or S70E ( Figure 5D ). Together, these results suggest that NPM-EE interferes with Cdc25C Ser216 phosphorylation and consequent cytoplasmic NPM-EE overrides stress-induced G 2 /M arrest and promotes leukemia blast cell proliferation To confirm the physiological significance of S10/S70 phosphorylation, we tested whether constitutive S10/S70 phosphorylation could overcome stress-induced G 2 /M cell cycle arrest. WT NPM or the NPM-EE mutant were retrovirally expressed human lymphoblast HSC536 cells deficient in the Fanconi group C gene (FANCC), which are hypersensitive to G 2 /M arrest induced by genotoxic drug mitomycin C (MMC), a potent crosslinker (41) . As expected, MMC treatment resulted in the accumulation of the vector-, WT NPM-or NPM-AAtransduced cells in G 2 /M phases of the cell cycle ( Figure 6A ). In contrast, expression of NPM-EE in HSC536 cells abrogated the MMC-induced G 2 /M arrest. This was associated with a strong increase in Cdk1 activity accompanied by reduced levels of Cdk1 Tyr15 in NPM-EE-expressing cells compared with those transduced with the control vector or WT NPM (Supplementary Figure S3 is available at Carcinogenesis Online).
The observation that NPM-EE promoted G 2 /M cell cycle progression prompted us to determine whether this double phosphomimetic mutant enhanced leukemic blast proliferation in a NOD/SCID xenograft model. We expressed WT NPM, NPM-AA or NPM-EE in human lymphoblasts and transplanted the transduced blasts into sublethally irradiated NOD/SCID mice. At 12 weeks after injection, the recipient mice were evaluated for establishment of xenograft. The BM from NPM-EE xenograft displayed significantly higher human Tyr15 proteins in asynchronized (left panel) or in mitotic (right panel). HSC536 cells were transduced with vector (V), WT-NPM (NPM), S10E (10E), S70E (70E), S10E/S70E (EE), S10A (10A), S70A (70A) or S10A/S70A (AA) retrovirus. Cdk1 , S10E (10E), S70E (70E) or S10E/S70E (EE) were used for direct western blot (lysates) or immunoprecipitation with anti-Cdk1 antibody (IP Cdk1). Cdc25C:Cdk1 ratio in each sample is calculated by Cdc25C/Cdk1. The WT NPM control sample at 0 point has been normalized as 1. (D) Whole cell extracts (top panel) and Cdk1-immunoprecipitation (bottom panel) in HEK293 cells were transfected with 0, 1 or 5 lg of plasmids expressing Flag-tagged WT-NPM (NPM), S10A (10A), S70A (70A) or S10A/S70A (AA) were used for direct western blot (lysates) or immunoprecipitation with anti-Cdk1 antibody (IP Cdk1). Cdc25C:Cdk1 ratio in each sample is calculated by Cdc25C/Cdk1. The WT NPM control sample at 0 point has been normalized as 1.
blast cells (human CD45/CD19 double stained) than those transplanted with the WT-NPM cells ( Figure 6B ). No xenograft was found in mice transplanted with NPM-AA or vector cells. Consistent with these, we observed increased population of blasts in the NPM-EE peripheral blood sample stained with Wright-Giemsa ( Figure 6C ).
Discussion
Phosphorylation of NPM has been long known to be intimately linked to its proliferative effect. Until recently few studies have been conducted to identify the regulatory role for NPM phosphorylation in cell cycle control. In the present study, we demonstrate a novel function of NPM on regulation of cell cycle progression, in which phosphorylation of NPM at the Ser10 and Ser70 residues in the CDK phosphorylation motifs controls cell cycle progression at G 2 /M transition through modulation of Cdk1 and Cdc25C activities. Specifically, we show that (i) cells expressing the phosphomimetic NPM mutants exhibited enhanced proliferation and G 2 /M cell cycle transition; (ii) Simultaneous inactivation of two CDK phosphorylation sites at Ser10 and Ser70 (NPM-AA) induced phosphorylation of Cdk1 at Tyr15 (Cdk1 Tyr15 ) and increased cytoplasmic accumulation of Cdc25C; (iii) Stress-induced Cdk1 Tyr15 and Cdc25C sequestration were suppressed by expression of the double phosphomimetic NPM mutant (NPM-EE); (iv) Phosphorylation of NPM at both Ser10 and Ser70 sites was required for proper interaction between Cdk1 and Cdc25C in mitotic cells; (v) NPM-EE directly bound to Cdc25C and prevented phosphorylation of Cdc25C at Ser216 during mitosis and (vi) NPM-EE overrided stress-induced G 2 /M arrest and increased leukemia blasts in a NOD/SCID xenograft model. Thus, our study not only demonstrates that phosphorylation of NPM contributes to the critical function of NPM in cell cycle control but also suggests that deregulated phosphorylation at certain sites of NPM may promote cell transformation.
NPM is a nucleolar phosphor-protein, which contains a number of putative recognition sites for various protein kinases (28, 29, 33, 42) . Here, we identified two novel phosphorylation sties of NPM. However, whether phosphorylation at these sites actually occur in vivo, how each phosphorylation affects the physiological roles of NPM and the identities of respective upstream kinases remain to be elucidated. Since NPM is a major proliferating protein, identification and characterization of kinases acting on NPM should conceivably shed light on not only regulatory mechanisms of cell proliferation but also specific roles of NPM in cell cycle checkpoint control.
Some important negative cell cycle regulators such as p53 and ARF antagonize the proliferation-promoting effect of CDKs and thus balancing cell cycle progression (43) . Much attention has focused on the regulation of negative cell cycle regulators by NPM but little is known about the effect of NPM on positive cell cycle regulators during cell cycle progression. In the present study, we show that phosphorylation of NPM at both Ser10 and Ser70 sites positively regulated Cdk1 activity. The conventional view of G 2 /M transition implicates a central role for Cdk1 and Cdc25C, with inhibitory phosphorylation on Cdk1 being dephosphorylated by the Cdc25C phosphatase, which in turn leads to an abrupt activation of Cdk1 (44, 45) . Intriguingly, phosphorylation of NPM at both Ser10 and Ser70 sites enhanced interaction between Cdk1 and Cdc25C and NPM-EE directly bound to Cdc25C and prevented phosphorylation of Cdc25C at Ser216 (Figure 4) . However, whether the NPM-Cdc25C interaction regulates Cdk1 activity or depends on Cdk1 and Cdc25C phosphorylation is an issue that will need to be investigated.
It has been demonstrated that a proper interaction between Cdk1 and Cdc25C is essential for successful mitosis (38, 40) . Our present data showed that simultaneous loss of the phosphorylation sites of NPM at S10 and S70 impairs the interaction between Cdk1 and Cdc25C in both mitotic cells and asynchronous cells ( Figure 4B ). This is correlated with the aberrant Cdk1 activity, which led to abnormal G 2 /M transition during the cell cycle, reflected by a delayed G 2 /M transition in NPM-AA cells but an early mitotic entry in NPM-EE cells ( Figure 1C and D) . Therefore, these results indicate that the interaction between Cdc25C and Cdk1 requires phosphorylation at both S10 and S70 sites.
The Cdc25C phosphatase is a key activator of Cdk1/cyclin B that controls M phase entry in eukaryotic cells (38) . Cdc25C is inactive during most of the cell cycle and gets activated at the onset of the M phase. Cdc25C activation is essential for cell cycle progression, whereas inhibition of Cdc25C is associated with the initiation of cell cycle checkpoints. Our data indicate that NPM-EE directly binds to Cdc25C and inhibits its phosphorylation at Ser216 (Figure 5A ), which prevents cytoplasmic sequestration of Cdc25C ( Figure 3C ). This is correlated with a reduction of inhibitory Cdk1 Tyr15 ( Figure 3A) and an increase in Cdk1 activity ( Figure 2B ), leading to a rapid G 2 /M transition ( Figure 1C ) and an early mitotic entry ( Figure 1D ). In this context, uncontrolled Cdk1 activation may have serious consequence in cells harboring DNA damage, such as those MMC-treated DNA repair-deficient FA cells (Figure 6A ), as high level of activated Cdk1 can override G 2 /M checkpoint driving the damaged cells into mitosis. 
NPM phosphorylation promotes G 2 /M transition
Another important observation is that constitutive phosphorylation of NPM at both Ser10 and Ser70 sites overrided stress-induced G 2 /M arrest induced by genotoxic agent MMC ( Figure 6A ). To our knowledge, the finding that simultaneous phosphorylation at the two CDK sites (S10/S70) drives G 2 /M transition indicates that cell cycle progression can be promoted by NPM phosphorylation and suggests that NPM phosphorylation can override this constraint in human cells. Our previous study shows that overexpression of NPM in hematopoietic cells suppresses stress-induced apoptosis through inhibition of p53 (20, 46) , probably the most important negative cell cycle regulator that mediates two major stress-dependent checkpoints, one at the G 1 /S transition and the other at the G 2 /M transition. While it is not clear whether NPM phosphorylation can override p53-mediated cell cycle arrest, the present study demonstrates that constitutive NPM phosphorylation can attenuate stress-induced G 2 /M arrest and alter cell fate decision toward cell cycle progression. There is wealth of evidence that expression of NPM is consistently elevated in actively proliferative and cancer cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . This corroborates the notion that deregulated NPM phosphorylation could prevent cell growth arrest through bypassing G 2 /M checkpoint leading to cell transformation.
Indeed, we were able to show that NPM-EE expression increased leukemic blasts in a NOD/SCID xenograft model ( Figure 6 ). While elevated expression of NPM has been reported in clinical leukemia samples and mouse leukemic stem cells as well as patient-derived leukemic cell lines (6,8,9 ), the role of NPM phosphorylation in leukemogenesis has not been investigated. It is possible that the constitutive phosphorylated NPM-EE functions to enhance self-renewal or block differentiation of hematopoietic stem cells (HSCs). In addition, since all upstream kinases of NPM identified thus far are cell cycle related (1, 28, 29, 33, 42) , examining whether regulation of NPM phosphorylation would affect hematopoiesis will provide valuable information on how NPM influences proliferation and differentiation of HSCs, which present the most frequent targets of leukemic transformation (47) . In this context, our study emphasizes how NPM phosphorylation can influence cell cycle progression and implicates deregulated NPM phosphorylation as a potential cancer-promoting event. 
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